Lipocine (LPCN) Asset Utilization Ratio (2018 - 2025)
Lipocine's (LPCN) Asset Utilization Ratio stood at 0.25 in Q3 2025, down 27.2% from 0.34 a year earlier but up 15.8% from the prior quarter.
Powered by 
Analysis
Lipocine (LPCN) Asset Utilization Ratio (2018 - 2025) Analysis & Trends
For FY2024, Lipocine's Asset Utilization Ratio came in at 0.49, up 422.5% from FY2023.
- Across earlier years, Asset Utilization Ratio came in at 0.09 in FY2023 (+747.8%), 0.01 in FY2022 (-97.3%) and 0.41 in FY2021.
- Quarterly Asset Utilization Ratio has ranged from 0.00 in Q3 2021 to 0.52 in Q4 2024 over the past five years.
- On a year-over-year basis, Asset Utilization Ratio has declined for three consecutive quarters, with growth averaging 205.3% over the last six quarters.
- Peak year-over-year performance for Asset Utilization Ratio in the last five years was growth of 854.4% in Q4 2023, against a decline of 99.5% in Q2 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at 0.22 (Q2 2025), 0.17 (Q1 2025) and 0.52 (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 0.49 |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 0.47 |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 0.52 |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 0.44 |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 0.53 |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 0.40 |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 0.58 |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 0.31 |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 0.47 |
| 10 | Lipocine | 11.71 Mn | -56.01 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 0.25 |
| Jun 30, 2025 | 0.22 |
| Mar 31, 2025 | 0.17 |
| Dec 31, 2024 | 0.52 |
| Sep 30, 2024 | 0.34 |
| Jun 30, 2024 | 0.44 |
| Mar 31, 2024 | 0.43 |
| Dec 31, 2023 | 0.12 |
| Sep 30, 2023 | 0.12 |
| Jun 30, 2023 | 0.00 |
| Mar 31, 2023 | 0.02 |
| Dec 31, 2022 | 0.01 |
| Sep 30, 2022 | 0.41 |
| Jun 30, 2022 | 0.37 |
| Mar 31, 2022 | 0.32 |
| Dec 31, 2021 | 0.35 |
| Sep 30, 2021 | 0.00 |
| Dec 31, 2020 | 0.01 |
| Sep 30, 2020 | 0.01 |
| Dec 31, 2019 | 0.01 |
API Access
Lipocine Asset Utilization Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=LPCN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "asset-utilization-ratio", "ticker": "LPCN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=LPCN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();